登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 回购股份期限：自董事会审议通过回购方案之日起12个月内。 ● 相关股东是否存在减持计划：截至公告披露日，公司董事、监事、高级管理人员、控股股东、实际控 制人及一致行动人、持股5%以上股东在未来三个月、未来六个月内暂无减持计划。若未来前述主体提 出减持计划，公司将根据相关法律法规规定及时履行信息披露义务。 ● 相关风险提示： 1、本次回购事项存在回购期限内股票价格持续超出回购价格上限，进而导致本次回购方案无法顺利实 施或者只能部分实施等不确定性风险； 2、本次回购存在因对公司股票交易价格产生重大影响的重大事项发生或公司董事会决定终止本次回购 方案等而无法实施的风险； 3、本次回购股份拟用于员工持股计划或股权激励，可能存在因员工持股计划或股权激励方案未能经公 司股东大会审议通过、股权激励认购对象放弃认购等原因，导致已回购股份无法全部转让的风险。本次 回购的股份若未能在股份回购实施完成之后法定期限内用于员工持股计 ...

Core Viewpoint - The Shenzhen Stock Exchange held its first collective performance briefing for listed companies in 2024, focusing on the theme "New Growth for Enterprises: Private Enterprises Competing in the Middle Stream," showcasing the latest developments of private enterprises and addressing investor concerns regarding technological innovation, tariff challenges, internationalization, and development strategies [1]. Group 1: Technological Innovation - Innovation is identified as the core driving force for the development of the private economy, with Shenzhen's private listed companies making significant investments in R&D, technology innovation, and patent accumulation [3]. - Jianfan Bio focuses on the R&D, production, and sales of biomedical materials and high-tech medical devices, particularly excelling in blood purification technology, and plans to enhance production management and diversify its product line [3]. - ZhiJian Electronics, a leader in consumer lithium-ion batteries, is committed to a forward-looking R&D strategy and aims to enhance its core competitive advantages while exploring market growth opportunities [3]. - Wanfu Bio sees digital pathology as a significant transformation opportunity and is developing comprehensive digital pathology solutions to reduce doctors' workloads [4]. - Xinlitai is exploring AI applications in drug discovery and clinical research to improve innovation efficiency and plans to deepen AI's role in drug design and data mining [4]. Group 2: Tariff Challenges - Companies are closely monitoring international trade policies and are implementing measures such as increasing domestic sales and developing new overseas markets to mitigate the impact of high tariffs imposed by the U.S. [6]. - Zongshen Power reported that its domestic sales accounted for 51.99% of total revenue in 2024, slightly higher than export business, and has taken proactive measures to address tariff risks [6]. - Yunjigroup highlighted that its supply chain has a high localization rate, effectively mitigating tariff fluctuations, and is capitalizing on new overseas projects due to the ongoing high prosperity cycle in the mining industry [7]. - Jianfan Bio is expanding into new markets while increasing its overseas business share, particularly in heavy liver disease and critical illness applications [7]. - Wanfu Bio has over 20 years of experience in international markets and continues to innovate to maintain growth in its international business despite tariff challenges [7]. Group 3: Development Trends - Shenzhen's private listed companies demonstrate resilience and vitality, with a significant number of companies contributing to economic development and technological innovation [9]. - As of March 2025, there are 2,181 private listed companies in Shenzhen, accounting for 76% of the total, with a combined market value of 22.65 trillion yuan, representing 69% of the total market value [9]. - In 2023, 582 private enterprises disclosed their annual reports, achieving a total revenue of 6.25 trillion yuan, a year-on-year increase of 6.62%, and a net profit of 419.9 billion yuan, a growth of approximately 1% [9]. - Jianfan Bio is investing in high-value resin and medical device projects, aiming to enhance market share and secure product supply [10]. - Xinlitai is transitioning from generic to innovative drugs, with increasing revenue contributions from new patented products [11].

Group 1 - Trump's recent shift in tone suggests a willingness to negotiate with China regarding tariffs, indicating a potential easing of tensions [8][9][12] - The volatility in Trump's stance has led to significant market reactions, with over $4 trillion evaporating from the stock market, representing 14% of the U.S. GDP [4][6] - The new tariff policies have adversely affected American citizens, with over 30% of their funds tied to the stock market, leading to concerns over pension funds [6][8] Group 2 - Trump's negotiations with Japan are seen as a strategy to pressure other countries into accepting stringent U.S. conditions, although Japan is cautious and not in a hurry to finalize agreements [19][21] - The Federal Reserve, led by Powell, has faced criticism from Trump for not aligning with his economic policies, particularly regarding interest rates and inflation concerns stemming from the tariff policies [23][25] - The ongoing trade tensions have prompted countries like Mexico and Canada to adopt ambiguous stances, while China is strengthening trade ties with other regions, potentially undermining U.S. leverage [33][35]

从指数持仓来看，中证中国内地企业全球工业综合指数十大权重分别为：宁德时代（6.03%）、京沪高 铁（1.82%）、汇川技术（1.37%）、中国建筑（1.16%）、三一重工（1.15%）、顺丰控股（1.03%）、 国电南瑞（0.96%）、中远海控（0.93%）、隆基绿能（0.92%）、中国中车（0.87%）。 金融界4月18日消息，A股三大指数收盘涨跌不一，中证中国内地企业全球工业综合指数 (CN工业综 合，H30377)报2273.92点。 数据统计显示，中证中国内地企业全球工业综合指数近一个月下跌10.58%，近三个月下跌2.51%，年至 今下跌4.95%。 据了解，中证中国内地企业全球行业综合指数系列从中证中国内地企业全球综合指数样本中按中证行业 分类标准进行分类，再以各自行业全部证券作为相应行业指数的指数样本，形成中证中国内地企业全球 行业综合指数系列，以反映中国内地企业中不同行业证券的整体表现。该指数以2004年12月31日为基 日，以1000.0点为基点。 从中证中国内地企业全球工业综合指数持仓的市场板块来看，深圳证券交易所占比46.82%、上海证券 交易所占比45.68%、香港证券交易所占比4.3 ...

Core Viewpoint - The stability of cash flow, rather than the scale of assets, is crucial for quality of life and investment success, especially in uncertain market conditions [1] Group 1: Cash Flow Index ETFs - A new batch of cash flow index ETFs has emerged, focusing on companies that generate real cash flow, serving as a strategy to navigate market volatility [1] - The China Securities Cash Flow Total Return Index has achieved a remarkable annual return of 40% in a turbulent market [2] Group 2: Investment Strategies - The free cash flow strategy is based on three winning logic points: 1. It focuses on real profitability by looking beyond financial statements, as free cash flow is based on actual cash inflows and outflows [4] 2. It combines high dividend yields with growth potential, providing a dual revenue engine [5] 3. It employs a dynamic rebalancing mechanism to capture undervalued stocks, allowing for timely adjustments to the index [9] Group 3: Performance Metrics - The index demonstrated resilience during bear markets, with a mere 2.76% decline in 2022 when the CSI 300 fell by 21.6% [6] - In bull markets, it outperformed with a 40.94% increase in 2024, achieving an excess return of 27 percentage points [6] - Since its inception in 2013, the index has accumulated a total return of 587.53% [6] Group 4: Index Composition - The index employs a "barbell strategy," including both cash-rich cyclical leaders like coal and petrochemicals, and high ROE growth sectors such as home appliances and automobiles [7] - The top ten constituent stocks, including China Shenhua and Midea Group, account for over 60% of the index, providing stable dividends while retaining growth potential [7] Group 5: Future Outlook - The market is expected to reassess value anchors, with state-owned enterprises facing value re-evaluation as cash flow assets become essential for risk-averse investments [9] - The upcoming issuance of the China Securities Cash Flow ETF may capture more certainty in the era of cash being king [9]

机构指出，多方增量资金明确，稳市资金更加积极，下方空间有限。 【财经日历】 2025全球机器学习技术大会。 | 3 | 盘前必读 | | 外盘怎么样 // | | | --- | --- | --- | --- | --- | | 名称 | | 现价 | 涨跌 | 涨跌幅 | | 道琼斯工业指数 | | 39142.23 | -527.16 | -1.33% | | 纳斯达克指数 | | 16286.45 c | -20.71 | -0.13% | 美股周四涨跌不一，投资者在假期前保持谨慎，同时关注贸易谈判进展与利率前景。 截至当天收盘，道琼斯工业平均指数下跌527.16点，报39142.23点，跌幅1.33%；标准普尔500指数上涨7.00点，报5282.70点，涨幅0.13%；纳斯达克综合指 数下跌20.71点，报16286.45点，跌幅0.13%。本周三大指数均录得周线下跌，标普500指数累计下跌1.5%，纳指下跌2.6%，道指跌幅达2.7%。 大型科技股走势分化。谷歌母公司Alphabet下跌1.4%，此前联邦法官裁定谷歌在在线广告技术市场存在非法垄断行为。微软下跌逾1%；亚马逊、Meta与特 斯拉微 ...

Core Viewpoint - The company, Southern Precision, announced that there have been no significant changes in its recent operational situation and external business environment despite a notable stock price fluctuation [1] Group 1: Stock Performance - Southern Precision's A-share stock price experienced a cumulative deviation of 20.00% over three consecutive trading days from April 15 to April 17, 2025, indicating abnormal trading activity [1] Group 2: Operational Status - The company confirmed that its recent operational situation has not undergone any major changes, and there are no undisclosed significant matters related to the company, its controlling shareholders, or actual controllers [1] Group 3: Regulatory Compliance - The company has received acceptance from the Shenzhen Stock Exchange regarding its refinancing application, adhering to regulatory requirements [1]

Group 1 - The article highlights the role of Industrial and Commercial Bank of China (ICBC) in providing timely financial support to small and micro enterprises in Fujian Province, particularly in Songxi County, to help them meet production demands and maintain orders [1][3] - A specific case is mentioned where a bamboo and wood crafts enterprise received a 5 million yuan credit loan within a week, which allowed them to secure raw materials and fulfill their orders despite facing cash flow challenges due to fluctuating raw material prices [1] - Another high-tech manufacturing enterprise in the region benefited from a tailored financial service plan, receiving a 5 million yuan loan to address funding gaps for raw material procurement and equipment upgrades, resulting in enhanced production efficiency and market competitiveness [3] Group 2 - ICBC's "financial special commissioner" mechanism is emphasized as a key strategy for providing targeted financial services to local enterprises, focusing on sectors such as specialty agriculture and green manufacturing [3] - The bank employs a systematic approach involving "checklist-based investigation, drip irrigation-style funding, and follow-up services" to ensure effective financial support for private enterprises in the area [3]

Investment Rating - The report maintains a "Recommended" rating for the company [4][6]. Core Views - The company has officially entered a phase of business reversal, with significant growth in net profit for 2024 and the first quarter of 2025, indicating a strong recovery [1][4]. - The company has made substantial progress in the research and development of precision components for robotics, achieving full sets of mature processes for key products [2][3]. - The company is actively expanding its production capacity and has plans to build additional automated production lines to enhance mass production consistency and stability [3][4]. Financial Performance Summary - For the first quarter of 2025, the company expects a net profit attributable to shareholders of 69-75 million yuan, representing a year-on-year growth of 31.54%-42.97% [1]. - The net profit for 2024 reached 254 million yuan, a year-on-year increase of 495.99%, with a significant rise in profit excluding non-recurring items [1]. - Revenue projections for 2024-2026 are 701 million, 836 million, and 960 million yuan, respectively, with corresponding net profits of 253 million, 369 million, and 507 million yuan [5][9]. Production and R&D Developments - The company has established a semi-automated production line for planetary roller screws, achieving a daily output of 50 sets [3]. - A comprehensive testing laboratory for screws has been set up, enabling the company to independently verify key parameters [3]. - The company has successfully developed multiple linear actuator products and micro-screw products in collaboration with clients, demonstrating its strong R&D capabilities [2][3].

证券代码：600698（A股） 900946（B股） 公告编号：临2025-008 证券简称：湖南天雁（A股） 天雁B股（B股） 湖南天雁机械股份有限公司 2024年度业绩快报 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 本公告所载 2024 年度主要财务数据为初步核算数据，未经会计师事务所审计，具体数据以湖南天雁机 械股份有限公司（以下简称"公司"）2024年年度报告中披露的数据为准，敬请投资者注意投资风险。 一、2024年度主要财务数据和指标 单位：元 币种：人民币 ■ 注：1、本报告期初数同法定披露的上年年末数。 2、上表数据以公司未经审计的合并报表数据填列。 二、经营业绩和财务状况情况说明 （一）经营业绩、财务状况 报告期内，公司实现营业收入43,250.56万元，利润总额291.02 万元，归属于上市公司股东的净利润 411.74万元，归属于上市公司股东的扣除非经常性损益的净利润-4,215.14 万元，归属于上市公司股东的 所有者权益76,885.69万元。 （二）影响经营业绩的主要因素及原因 1. 20 ...